Matthew Hawryluk - Sep 9, 2025 Form 4 Insider Report for Predictive Oncology Inc. (POAI)

Role
Director
Signature
/s/ Josh Blacher, Attorney-in-Fact
Stock symbol
POAI
Transactions as of
Sep 9, 2025
Transactions value $
$0
Form type
4
Date filed
9/11/2025, 05:45 PM
Previous filing
May 17, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hawryluk Matthew Director C/O PREDICTIVE ONCOLOGY INC., 91 43RD STREET SUITE 110, PITTSBURGH /s/ Josh Blacher, Attorney-in-Fact 2025-09-11 0001754470

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction POAI Common Stock Award $0 +64.7K +681.7% $0.00 74.2K Sep 9, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The grant consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs shall vest in full on October 31, 2025, subject to continued service through the applicable vesting date.